Proven Benefits For Cardiovsacular Risk Reduction In addition to promoting weight loss, semaglutide has been shown to provide a 20% relative risk reduction in major adverse cardiovascular events, such as heart attack and stroke, when added to standard cardiovascular care
In the direct-to-consumer market, however, this approach pits two value propositions against each other: helping patients build habits that allow them to discontinue GLP-1s versus encouraging long-term use through maintenance dosing
When labs are ordered in GLP-1 treatment, providers typically look at markers that help evaluate metabolic function, organ health, and potential risk factors: A1C and fasting glucose: to assess baseline glycemic control [2] Kidney function: to monitor dehydration risk and fluid balance, which GLP-1-related gastrointestinal side effects can affect [3] Liver enzymes: to ensure safe medication clearance and dosing [4] Lipid panel: to track key cardiometabolic markers that often shift with weight loss [5] Thyroid panel: to rule out thyroid disorders that can contribute to weight changes or mimic weight-related symptoms [6] Complete blood count and electrolytes: to check for underlying health issues or imbalances that could complicate early treatment [7] Important: Because Peak Wellness relies primarily on intake-based evaluation, patients with known medical conditions or incomplete health histories may want to discuss whether additional testing would be beneficial before starting treatment
How to Maximize Your HSA To maximize the potential of your HSA, youll want to try and preserve the plan contributions
So, by taking both, you increase your chances of stopping hair loss and regrowing hair
